1-20 of 34
David Goldenberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer

Darrin V. Bann, Qunyan Jin, Kathryn E. Sheldon, Kenneth R. Houser, Lan Nguyen, Joshua I. Warrick, Maria J. Baker, James R. Broach, Glenn S. Gerhard, David Goldenberg
Journal: Cancer Research
Cancer Res (2019) 79 (21): 5490–5499.
https://doi.org/10.1158/0008-5472.CAN-19-0721
Published: 01 November 2019
View articletitled, Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer
Open the PDF for Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 1708: An integrated framework for genome analysis reveals numerous previously unrecognizable structural variants in leukemia patients’ samples

James R. Broach, Jie Xu, Emily Schleicher, Christopher Pool, Max Hennessy, Kathryn Sheldon, Charyguly Annageldiyev, Arati Sharma, Yuanyuan Chang, Alex Hastie, Barbara Miller, David Goldenberg, David Claxton, George-Lucian Moldovan, Feng Yue
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1708.
https://doi.org/10.1158/1538-7445.AM2019-1708
Published: 01 July 2019
View articletitled, Abstract 1708: An integrated framework for genome analysis reveals numerous previously unrecognizable structural variants in leukemia patients’ samples
Journal Articles

Abstract 994: Diagnosing leukemia structural variations via a novel genome mapping approach

Christopher Pool, Jie Xu, Darrin Bann, David Goldenberg, Arati Sharma, David Claxton, Feng Yue, James Broach
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 994.
https://doi.org/10.1158/1538-7445.AM2017-994
Published: 01 July 2017
View articletitled, Abstract 994: Diagnosing leukemia structural variations via a novel genome mapping approach
Journal Articles

Abstract 2527: The drug combination sorafenib and quinacrine targets the expression of Mcl-1 - an anti-apoptotic protein and candidate prognostic factor in Anaplastic Thyroid Cancer (ATC)

Junaid Abdulghani, Jean-Nicholas Gallant, Prashanth Gokare, Timothy Cooper, Tiffany Whitcomb, Jiangang Liao, Jing Liu, David Goldenberg, Niklas K. Finnberg, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2527.
https://doi.org/10.1158/1538-7445.AM2015-2527
Published: 01 August 2015
View articletitled, Abstract 2527: The drug combination sorafenib and quinacrine targets the expression of Mcl-1 - an anti-apoptotic protein and candidate prognostic factor in Anaplastic Thyroid Cancer (ATC)
Journal Articles

Abstract 608: Quinacrine and sorafenib as potential combination for anaplastic thyroid carcinoma.

Junaid Abdulghani, Jean-Nicolas Gallant, Tiffany Whitcomb, David Dicker, David Goldenberg, Charles D. Smith, Niklas Finnberg, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 608.
https://doi.org/10.1158/1538-7445.AM2013-608
Published: 15 April 2013
View articletitled, Abstract 608: Quinacrine and sorafenib as potential combination for anaplastic thyroid carcinoma.
Journal Articles

Abstract 3722: Quinacrine and sorafenib combination as potential therapy for anaplastic thyroid cancer

Junaid Abdulghani, Jean-Nicolas Gallant, Tiffany Whitcomb, David Dicker, Charles D. Smith, David Goldenberg, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3722.
https://doi.org/10.1158/1538-7445.AM2012-3722
Published: 15 April 2012
View articletitled, Abstract 3722: Quinacrine and sorafenib combination as potential therapy for anaplastic thyroid cancer
Journal Articles

Abstract 1803: HLA-DR-targeting tetrameric IFNα2b immunocytokine has potent in vitro and in vivo activity in myelomas, lymphomas and leukemias

Edmund Rossi, Diane Rossi, Thomas Cardillo, Rhona Stein, Anju Nair, Maria Zalath, David Goldenberg, Chien-Hsing Chang
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1803.
https://doi.org/10.1158/1538-7445.AM2011-1803
Published: 15 April 2011
View articletitled, Abstract 1803: HLA-DR-targeting tetrameric IFNα2b immunocytokine has potent in vitro and in vivo activity in myelomas, lymphomas and leukemias
Journal Articles

Abstract 4289: Early study on LGR5/GPR49 molecule as a potential colon cancer stem cell target for the antibody conjugated drug treatment

Weiguang Mao, Janet Tien, David Goldenberg, Scott Stawicki, Rajesh Vij, Xiaoling Xia, Jo-Anne Hongo, Sarajane Ross, Kathy Kozak, Ron Firestein, Yan Wu, Susan Spencer, Paul Polakis
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4289.
https://doi.org/10.1158/1538-7445.AM10-4289
Published: 15 April 2010
View articletitled, Abstract 4289: Early study on LGR5/GPR49 molecule as a potential colon cancer stem cell target for the antibody conjugated drug treatment
Journal Articles

Abstract #3237: A veltuzumab-IFN \#945;2b conjugate with potent in vitro and in vivo anti-lymphoma activity

Edmund Rossi, David Goldenberg, Thomas Cardillo, Diane Nordstrom, Chien-Hsing Chang
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3237.
Published: 01 May 2009
View articletitled, Abstract #3237: A veltuzumab-IFN \#945;2b conjugate with potent in vitro and in vivo anti-lymphoma activity
Journal Articles

Abstract #1228: Milatuzumab (humanized anti-CD74 mAb) targets and kills B-cell malignancies, and blocks signal transduction through CD74

Rhona Stein, Habibe Karacay, Robert Sharkey, Mitchell Smith, David Goldenberg
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1228.
Published: 01 May 2009
View articletitled, Abstract #1228: Milatuzumab (humanized anti-CD74 mAb) targets and kills B-cell malignancies, and blocks signal transduction through CD74
Journal Articles

Abstract #3233: Targeted therapy of human colonic, lung, and pancreatic cancer xenografts, growing in nude mice, with potent antibody conjugates of SN-38

Serengulam Govindan, Thomas Cardillo, Sung-Ju Moon, David Goldenberg
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3233.
Published: 01 May 2009
View articletitled, Abstract #3233: Targeted therapy of human colonic, lung, and pancreatic cancer xenografts, growing in nude mice, with potent antibody conjugates of SN-38
Journal Articles

Abstract #5410: Early detection of pancreatic carcinoma

David Gold, David Modrak, Guy Newsome, Zarir Karanjawala, Ralph Hruban, Michael Goggins, David Goldenberg
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5410.
Published: 01 May 2009
View articletitled, Abstract #5410: Early detection of pancreatic carcinoma
Journal Articles

Abstract #3760: Reactive oxygen species formation leads to increased mitochondrial sphingomyelinase activity in pancreatic cancer cells

David Modrak, Guy Newsome, Kristen Mattei, David Goldenberg, David Gold
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3760.
Published: 01 May 2009
View articletitled, Abstract #3760: Reactive oxygen species formation leads to increased mitochondrial sphingomyelinase activity in pancreatic cancer cells
Journal Articles

Abstract #1255: HLA-DR as a target for therapy of human and canine B-cell malignancies

Rhona Stein, Cheryl Balkman, Rodney Page, David Goldenberg
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1255.
Published: 01 May 2009
View articletitled, Abstract #1255: HLA-DR as a target for therapy of human and canine B-cell malignancies
Journal Articles

Abstract #1229: Multiple signaling pathways of hexavalent anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized monoclonal antibodies correlate with improved anti-lymphoma properties

Pankaj Gupta, David Goldenberg, Chien-Hsing Chang
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1229.
Published: 01 May 2009
View articletitled, Abstract #1229: Multiple signaling pathways of hexavalent anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized monoclonal antibodies correlate with improved anti-lymphoma properties
Journal Articles

Abstract #5485: Expression of CD74 in pancreatic and colorectal carcinomas as a basis for milatuzumab immunotherapy

David Gold, Jack Burton, Jatin Desani, Rhona Stein, David Goldenberg
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5485.
Published: 01 May 2009
View articletitled, Abstract #5485: Expression of CD74 in pancreatic and colorectal carcinomas as a basis for milatuzumab immunotherapy
Journal Articles

Abstract #3256: Generation of a novel class of tetrameric granulocyte colony-stimulating factor with improved biological activity

Yang Wang, Meiyu Loo, Thomas Cardillo, David Goldenberg, Chien-Hsing Chang
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3256.
Published: 01 May 2009
View articletitled, Abstract #3256: Generation of a novel class of tetrameric granulocyte colony-stimulating factor with improved biological activity
Journal Articles

Abstract #LB-2: Placental growth factor (PlGF) stabilizes CK19 and vimentin expression independently of mRNA and protein synthesis in a breast cancer cell line.

Alice Taylor, Evelyn Leon, David Goldenberg
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): LB-2.
Published: 01 May 2009
View articletitled, Abstract #LB-2: Placental growth factor (PlGF) stabilizes CK19 and vimentin expression independently of mRNA and protein synthesis in a breast cancer cell line.
Journal Articles

Abstract #SY10-4: Genetically engineered mouse models for neuroblastoma: applications to developmental therapeutics.

William Weiss, Matthew Grimmer, Melissa Itsara, Yvan Chanthery, Anders Persson, Justin Chen, Kim Nguyen, Slava Yakovenko, Sabine Mueller, David Goldenberg, Grace Kim, Daphne Haas-Kogan, Katherine Matthay, Louis Chesler
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): SY10-4.
Published: 01 May 2009
View articletitled, Abstract #SY10-4: Genetically engineered mouse models for neuroblastoma: applications to developmental therapeutics.
Journal Articles

Abstract #3255: Tetrameric erythropoietin anchored on IgG with improved biological activity.

Diane Nordstrom, David Goldenberg, Thomas Cardillo, Edmund Rossi, Chien-Hsing Chang
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3255.
Published: 01 May 2009
View articletitled, Abstract #3255: Tetrameric erythropoietin anchored on IgG with improved biological activity.